receptor tyrosine kinase inhibitor

Related by string. * Receptor . Receptors . receptors : estrogen receptor ER . selective estrogen receptor . estrogen receptor positive / Tyrosine : VEGF receptor tyrosine kinases . Bruton tyrosine kinase Btk . Bruton tyrosine kinase / kinases . Kinase : Aurora kinase . anaplastic lymphoma kinase ALK / Inhibitor . Inhibitors : proton pump inhibitors . proton pump inhibitors PPIs * *

Related by context. Frequent words. (Click for all words.) 76 multi kinase inhibitor 76 liposomal formulation 75 Dasatinib 74 Amrubicin 74 pertuzumab 74 tyrosine kinase inhibitor 73 Epratuzumab 73 Irinotecan 73 forodesine 73 Carfilzomib 72 Torisel 72 Zolinza 72 kinase inhibitor 72 orally bioavailable 71 superficial bladder cancer 71 mTOR inhibitor 71 phase IIb clinical 71 ZD# [001] 71 ganetespib 71 metastatic renal cell carcinoma 71 Bortezomib 71 FLT3 71 elotuzumab 71 Panzem R 71 CCX# 71 bendamustine 71 Pivotal Phase III 71 Traficet EN 71 angiogenesis inhibitor 71 MEK inhibitor 71 HER2 positive metastatic breast 70 IMC A# 70 SERMs 70 humanized anti 70 GSK# [001] 70 BMS # 70 mRCC 70 humanized monoclonal antibody 70 BAY #-# 70 myeloproliferative disorders 70 mycophenolate mofetil 70 xenograft models 70 gastrointestinal stromal tumors GIST 70 multiple myeloma MM 70 Lenalidomide 70 SAR# [004] 70 EGFR inhibitors 70 Nexavar ® 70 ATL# [001] 70 Bevacizumab 70 anticancer compound 70 proteasome inhibitors 69 R sorafenib tablets 69 Mipomersen 69 selective inhibitor 69 CYC# 69 Phase Ib clinical 69 immunomodulator 69 Voreloxin 69 docetaxel chemotherapy 69 Herceptin trastuzumab 69 relapsed refractory multiple myeloma 69 Laquinimod 69 bevacizumab Avastin 69 tigecycline 69 PEG SN# 69 Tesetaxel 69 GV# [001] 69 goserelin 69 Everolimus 69 talabostat 69 tyrosine kinase inhibitors 69 metastatic hormone refractory 69 Cethromycin 69 Ofatumumab 69 Eltrombopag 69 Gemcitabine 69 HGS ETR1 69 OXi# 69 androgen independent 68 alpha blocker 68 SCH # 68 colorectal carcinoma 68 receptor antagonists 68 EOquin 68 gastrointestinal stromal tumors 68 Vandetanib 68 luteinizing hormone releasing 68 Aurora kinase 68 Sym# 68 nucleoside analogue 68 Metastatic Melanoma 68 Phase III Clinical Trial 68 humanized antibody 68 Sorafenib 68 biologic therapy 68 tanespimycin 68 SUTENT 68 PXD# 68 imatinib mesylate 68 EGFr

Back to home page